JP2008512117A5 - - Google Patents

Download PDF

Info

Publication number
JP2008512117A5
JP2008512117A5 JP2007531167A JP2007531167A JP2008512117A5 JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5 JP 2007531167 A JP2007531167 A JP 2007531167A JP 2007531167 A JP2007531167 A JP 2007531167A JP 2008512117 A5 JP2008512117 A5 JP 2008512117A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
domain
protein
fusion protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007531167A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008512117A (ja
JP4764881B2 (ja
Filing date
Publication date
Priority claimed from US10/939,262 external-priority patent/US7807174B2/en
Application filed filed Critical
Publication of JP2008512117A publication Critical patent/JP2008512117A/ja
Publication of JP2008512117A5 publication Critical patent/JP2008512117A5/ja
Application granted granted Critical
Publication of JP4764881B2 publication Critical patent/JP4764881B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007531167A 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス Expired - Fee Related JP4764881B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/939,262 2004-09-10
US10/939,262 US7807174B2 (en) 2002-11-22 2004-09-10 Class of therapeutic protein based molecules
PCT/US2005/025831 WO2006031291A2 (en) 2004-09-10 2005-07-21 A novel class of therapeutic protein based molecules

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010153231A Division JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Publications (3)

Publication Number Publication Date
JP2008512117A JP2008512117A (ja) 2008-04-24
JP2008512117A5 true JP2008512117A5 (enExample) 2009-12-17
JP4764881B2 JP4764881B2 (ja) 2011-09-07

Family

ID=36060467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007531167A Expired - Fee Related JP4764881B2 (ja) 2004-09-10 2005-07-21 新規の治療タンパク質ベースの分子クラス
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010153231A Expired - Fee Related JP5307082B2 (ja) 2004-09-10 2010-07-05 新規の治療タンパク質ベースの分子クラス

Country Status (16)

Country Link
US (2) US7807174B2 (enExample)
EP (4) EP3530734A1 (enExample)
JP (2) JP4764881B2 (enExample)
KR (1) KR20070064619A (enExample)
CN (2) CN101426906B (enExample)
AU (1) AU2005285461B2 (enExample)
BR (1) BRPI0515646B8 (enExample)
CA (2) CA2823429C (enExample)
DK (3) DK1786902T3 (enExample)
ES (3) ES2626845T3 (enExample)
IL (3) IL181779A (enExample)
PT (3) PT3018204T (enExample)
RU (1) RU2468080C2 (enExample)
TR (1) TR201905393T4 (enExample)
WO (1) WO2006031291A2 (enExample)
ZA (1) ZA200702915B (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100210528A1 (en) * 1999-03-05 2010-08-19 Leland Shapiro Compositions, methods and uses for inhibition and/or treatment of influenza infection
US7807174B2 (en) * 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
AU2003294401C1 (en) * 2002-11-22 2008-09-18 Ansun Biopharma, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
US8512710B2 (en) 2002-11-22 2013-08-20 Ansun Biopharma, Inc. Class of therapeutic protein based molecules
WO2006051864A1 (ja) * 2004-11-10 2006-05-18 Hitachi Chemical Co., Ltd. 接着補助剤付金属箔及びそれを用いたプリント配線板
CA2627323A1 (en) * 2005-10-25 2007-05-03 Mnd Diagnostic Ltd. Compositions for- detecting of influenza viruses and kits and methods using same
AU2013237761B8 (en) * 2006-01-24 2015-06-04 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
WO2007114881A1 (en) * 2006-01-24 2007-10-11 Nexbio, Inc. Technology for preparation of macromolecular microspheres
AU2015215955B2 (en) * 2006-01-24 2016-12-01 Ansun Biopharma, Inc. Technology for preparation of macromolecular microspheres
US8273381B1 (en) * 2006-04-14 2012-09-25 Auburn University Compositions for and methods of controlling olfactory responses to odorants
WO2008076938A1 (en) * 2006-12-14 2008-06-26 University Of Iowa Research Foundation Method of making cyclic polypeptides with inteins
CA2676686C (en) * 2007-02-20 2015-12-15 Dsm Ip Assets B.V. Novel sialidase
EP2178852B9 (en) 2007-08-03 2016-06-22 Romark Laboratories, L.C. Alkylsulfonyl-substituted thiazolide compounds
CN105853415A (zh) 2009-05-12 2016-08-17 罗马克实验室有限公司 卤代烷基杂芳基苯甲酰胺化合物
BRPI1014322A2 (pt) 2009-06-26 2015-08-25 Romark Lab Lc Método para tratar infecção, e para interromper ou evitar a produção de partículas virais infecciosas, combinação, e, composição farmacêutica.
JP5852568B2 (ja) * 2009-07-31 2016-02-03 ダニスコ・ユーエス・インク 修飾されたプレ‐プロ領域を有するプロテアーゼ
AU2010315024B2 (en) * 2009-11-06 2015-02-12 Nexbio, Inc. Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract
WO2013123521A1 (en) * 2012-02-17 2013-08-22 Nexbio, Inc. Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients
WO2014005107A2 (en) * 2012-06-28 2014-01-03 Ansun Biopharma, Inc. Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture
JP2015527310A (ja) 2012-06-28 2015-09-17 アンサン バイオファーマ, インコーポレイテッドAnsun Biopharma, Inc. 下気道および中枢気道への送達用微粒子製剤ならびに製造方法
DK3165232T3 (da) 2012-12-24 2019-09-16 Coagulant Therapeutics Corp Faktor vii-polypeptider med kortvarig virkning
CN110295114A (zh) 2013-03-15 2019-10-01 安迅生物制药公司 蛋白纯化的新颖方法
PT3524618T (pt) 2013-03-15 2023-06-06 Gladiator Biosciences Inc Domínios gla como agentes de marcação
US20160101161A1 (en) * 2013-06-03 2016-04-14 Ansun Biopharma, Inc. Anti-viral therapeutic for infection of the eye
WO2014201027A2 (en) * 2013-06-10 2014-12-18 Ansun Biopharma, Inc. Treatment of merkel cell polyomavirus infection
US10300116B2 (en) 2013-06-10 2019-05-28 Ansun Biopharma, Inc. Treatment for BK polyomavirus infection
WO2015184356A1 (en) 2014-05-30 2015-12-03 Ansun Biopharma, Inc. Treatment of middle east respiratory syndrome coronavirus
US10328128B2 (en) 2014-09-17 2019-06-25 Ansun Biopharma, Inc. Treatment of infection by human enterovirus D68
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
WO2016115616A1 (en) * 2015-01-21 2016-07-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health Inhibition of cellular proteases as treatment for influenza
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
SG10202100652VA (en) * 2015-07-21 2021-03-30 Univ Jefferson Gene therapies for neurodegenerative disorders targeting ganglioside biosynthetic pathways
US12171808B2 (en) 2016-05-20 2024-12-24 Octapharma Ag Glycosylated VWF fusion proteins with improved pharmacokinetics
ES2947312T3 (es) 2016-07-01 2023-08-04 Univ Leland Stanford Junior Conjugados para la edición dirigida de la superficie celular
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3630968B8 (en) * 2017-05-26 2024-07-03 Genovis AB Enzymes for glycan analysis
JP2020533976A (ja) 2017-09-05 2020-11-26 グラディエーター バイオサイエンシーズ インコーポレイテッド エキソソームを標的化する方法
JP7462560B2 (ja) 2018-01-03 2024-04-05 パレオン ファーマシューティカルズ インコーポレイテッド 組換えヒトシアリダーゼ、シアリダーゼ融合タンパク質およびそれらの使用方法
GB201800274D0 (en) * 2018-01-08 2018-02-21 Enzymatica Ab Novel treatments
GB201803197D0 (en) 2018-02-27 2018-04-11 Pneumagen Ltd Viral treatment
CN112739374A (zh) * 2018-07-20 2021-04-30 安迅生物制药公司 唾液酸酶向癌细胞、免疫细胞和肿瘤微环境的递送
CN109991649B (zh) * 2019-03-26 2021-04-06 华中科技大学 一种制备无机闪烁体膜的方法
JP7343890B2 (ja) * 2019-04-26 2023-09-13 国立大学法人東海国立大学機構 シアリダーゼ活性を有する酵素剤及びその利用
CN110038122A (zh) * 2019-05-23 2019-07-23 武汉真福医药股份有限公司 枯草杆菌纤溶酶在治疗支气管炎药物中的应用
MX2021016040A (es) 2019-07-03 2022-03-11 Aillis Inc Composicion farmaceutica para el tratamiento de infecciones de virus de influenza.
CN111450236B (zh) * 2020-02-25 2023-04-07 西北大学 一种用于阻断冠状病毒感染的制剂
WO2021217053A1 (en) * 2020-04-24 2021-10-28 Rezolute, Inc. Plasma kallikrein inhibitors for the treatment of ards and related conditions
WO2021252129A1 (en) * 2020-06-10 2021-12-16 The Penn State Research Foundation Process and system to lessen human coronavirus transmission and spread
WO2022147481A1 (en) 2020-12-30 2022-07-07 Ansun Biopharma Inc. Combination therapy of an oncolytic virus delivering a foreign antigen and an engineered immune cell expressing a chimeric receptor targeting the foreign antigen
CN117836432A (zh) * 2021-06-09 2024-04-05 微生物机器公司 用于检测患病细胞的工程化微生物
JP2024540218A (ja) 2021-11-02 2024-10-31 アンサン バイオファーマ， インコーポレイテッド Ｄａｓ１８１バリアント組成物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439089A (en) 1968-03-27 1969-04-15 Merck & Co Inc Medicated hard candy
ATE135403T1 (de) * 1987-03-10 1996-03-15 New England Biolabs Inc Herstellung und reinigung eines proteins, das mit einem bindungsprotein fusioniert ist
US5643758A (en) 1987-03-10 1997-07-01 New England Biolabs, Inc. Production and purification of a protein fused to a binding protein
RU2054180C1 (ru) 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5376633A (en) 1992-09-30 1994-12-27 Lezdey; John Method for deactivating viruses in blood component containers
US5985859A (en) * 1994-04-14 1999-11-16 The University Of Alabama Methods of inhibiting bacterial sialidase
WO1995034662A1 (en) * 1994-06-14 1995-12-21 Gist-Brocades B.V. Thermostable xylanases
CN100409844C (zh) * 1995-02-27 2008-08-13 吉里德科学公司 神经氨酸苷酶抑制剂
GB9513683D0 (en) * 1995-07-05 1995-09-06 Ciba Geigy Ag Products
WO1998031817A2 (en) 1997-01-14 1998-07-23 Hopital Sainte-Justine Human lysosomal sialidase and therapeutic uses thereof
US6251392B1 (en) 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent
US6737511B1 (en) 1999-08-16 2004-05-18 The United States Of America As Represented By The Department Of Health And Human Services Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
US20020025320A1 (en) 1999-08-20 2002-02-28 Prosper Boyaka Sialidases as mucosal adjuvants
CN1405562A (zh) * 2002-10-24 2003-03-26 肖洪武 一种唾液酸酶测定试剂
US7807174B2 (en) 2002-11-22 2010-10-05 Nexbio, Inc. Class of therapeutic protein based molecules
AU2003294401C1 (en) 2002-11-22 2008-09-18 Ansun Biopharma, Inc. Broad spectrum anti-viral therapeutics and prophylaxis
DE10258400A1 (de) * 2002-12-13 2004-06-24 N.V. Nutricia Trans-Sialidasen aus Trypanosoma congolense
WO2007114881A1 (en) 2006-01-24 2007-10-11 Nexbio, Inc. Technology for preparation of macromolecular microspheres

Similar Documents

Publication Publication Date Title
RU2007112502A (ru) Новый класс терапевтических белковых молекул
JP2021512899A5 (enExample)
JP2010524849A5 (enExample)
US20180360749A1 (en) Methods and compositions for delivery of medicaments to the lungs
CN116033926A (zh) 针对ace2靶向病毒可用的结合蛋白
KR20220010478A (ko) 기도 감염의 치료 또는 예방용 서브유닛 백신
AU2015202864A1 (en) Fibronectin type III domain based scaffold compositions, methods and uses
JP2023029957A5 (enExample)
JP2005512522A (ja) Ｉｌ−１３ムテインタンパク質、抗体、組成物、方法および使用
JP2014506450A5 (enExample)
WO2024239980A1 (zh) 重组表达蛋白在预防/或治疗呼吸道疾病中的应用
JP2025521082A5 (enExample)
AU2010306840A1 (en) Recombinant human CC10 protein for treatment of influenza
JP7009625B2 (ja) Ｈ３ｎ２亜型インフルエンザウイルスのヘマグルチニンタンパク質の突然変異体及びその使用
CN117186239A (zh) 融合蛋白及其应用
CN116782920A (zh) 用于治疗病毒感染的神经毡蛋白和血管紧张素转化酶2融合肽
JP2023542453A5 (enExample)
JP2024525213A5 (enExample)
JP2026515377A (ja) 神経系修復のためのタンパク質チロシンホスファターゼ楔ドメインペプチドダイマー
CN117050166B (zh) 中和呼吸道合胞病毒的c-型单域抗体及应用
JP2024041848A (ja) 新規な抗炎症性ペプチド及びその用途
TW202317600A (zh) 預防多種病毒感染的多價疫苗
JP2009513689A5 (enExample)
EP3638282A1 (en) Hydrochloride salts of c5a receptor agonist peptides
CN115772227A (zh) 新型冠状病毒SARS-CoV-2的Delta变异株疫苗与应用